Page last updated: 2024-12-07

(6ar-trans)-isomer of tetrahydrocannabivarin 9

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth

You're asking about the **(6aR,trans)-isomer of tetrahydrocannabivarin (THCV)**.

Here's a breakdown:

* **Tetrahydrocannabivarin (THCV)** is a cannabinoid found in cannabis, similar to THC (tetrahydrocannabinol). It's a non-psychoactive compound, meaning it doesn't produce the high associated with THC.
* **(6aR,trans)-isomer** refers to the specific arrangement of atoms in the THCV molecule. This specific isomer is distinguished by:
* **6aR:** The 6aR designation indicates the stereochemistry at the 6th carbon atom in the molecule. R indicates that the substituent at that position is oriented in a specific way (clockwise, if you're looking at it in a certain way).
* **trans:** The trans configuration indicates that two specific groups on the molecule are positioned on opposite sides of the molecule.

**Why is the (6aR,trans)-isomer important for research?**

* **Distinct Pharmacological Activity:** The (6aR,trans)-isomer of THCV shows distinct pharmacological activity compared to other isomers of THCV. It interacts with the endocannabinoid system, particularly with the CB1 receptor, but in a different way than THC.
* **Potential Therapeutic Applications:** Research suggests that (6aR,trans)-THCV might have therapeutic potential for conditions like:
* **Obesity and metabolic disorders:** It could potentially help regulate appetite and improve insulin sensitivity.
* **Seizure disorders:** Some studies indicate it might have anticonvulsant properties.
* **Anxiety and depression:** Its interaction with the endocannabinoid system suggests potential for mood regulation.

**Important Note:** While research is promising, it's crucial to remember that (6aR,trans)-THCV is still under investigation. Its safety and efficacy for specific conditions need further study.

**In summary:** The (6aR,trans)-isomer of THCV is a distinct molecular configuration that has garnered attention due to its potential therapeutic applications. However, further research is needed to fully understand its effects and potential uses in medicine.

Cross-References

ID SourceID
PubMed CID93147
CHEMBL ID2387541
SCHEMBL ID6856739
MeSH IDM0308286

Synonyms (44)

Synonym
(6ar,10ar)-6,6,9-trimethyl-3-propyl-6a,7,8,10a-tetrahydrobenzo[c]chromen-1-ol
CHEMBL2387541
thcv
.delta.9-tetrahydrocannabivarin
o-4394
gwp-42004
thc-v
gwp42004
6h-dibenzo(b,d)pyran-1-ol, 6a,7,8,10a-tetrahydro-6,6,9-trimethyl-3-propyl-, (6ar-trans)-
31262-37-0
tetrahydrocannabivarin
unii-i5ye3i47d8
i5ye3i47d8 ,
delta9-tetrahydrocannabivarin
gtpl6418
delta9-thcv
(-)-.delta.9-trans-tetrahydrocannabivarin
cannabivarol, .delta.9-tetrahydro-
6h-dibenzo(b,d)pyran-1-ol, 6a,7,8,10a-tetrahydro-6,6,9-trimethyl-3-propyl-, (6ar,10ar)-
SCHEMBL6856739
6,6,9-trimethyl-3-propyl-6a,7,8,10a-tetrahydro-6h-benzo[c]chromen-1-ol-, (6ar-trans)-
6h-dibenzo[b,d]pyran-1-ol, 6a,7,8,10a-tetrahydro-6,6,9-trimethyl-3-propyl-, (6ar-trans)-
.delta.9-trans-tetrahydrocannabivarin
6h-dibenzo[b,d]pyran-1-ol, 6a,7,8,10a-tetrahydro-6,6,9-trimethyl-3-propyl-, (-)-
cannabidivarol, .delta.1-tetrahydro-
ZROLHBHDLIHEMS-HUUCEWRRSA-N
.delta.9-tetrahydrocannabivarol
6h-dibenzo[b,d]pyran-1-ol, 6a,7,8,10a-tetrahydro-6,6,9-trimethyl-3-propyl-, (6ar,10ar)-
.delta.1-tetrahydrocannabidivarol
HY-U00342
CS-7377
DB11755
DTXSID10893920
(6ar,10ar)-6,6,9-trimethyl-3-propyl-6a,7,8,10a-tetrahydro-6h-benzo[c]chromen-1-ol
delta 9-tetrahydrocannabivarin (thcv) 100 microg/ml in methanol
delta9-tetrahydrocannabivarin 1000 microg/ml in methanol
bdbm50511105
(6ar,10ar)-6,6,9-trimethyl-3-propyl-6h,6ah,7h,8h,10ah-benzo[c]isochromen-1-ol
delta9-tetrahydrocannabivarin (thcv) 10 microg/ml in methanol
delta9-tetrahydrocannabivarin (thcv) 250 microg/ml in acetonitrile
i8e ,
AKOS040762420
tetrahydrocannabivarin (thcv), 1mg/ml in methanol
(6ar,10ar)-6,6,9-trimethyl-3-propyl-6a,7,8,10a-tetrahydro-6h-dibenzo[b,d]pyran-1-ol
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Protein Targets (17)

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Transient receptor potential cation channel subfamily A member 1Homo sapiens (human)IC50 (µMol)1.97000.05102.47257.5000AID1845627; AID1845628
Cannabinoid receptor 1Homo sapiens (human)IC50 (µMol)0.01310.00010.275310.0000AID1674384
Cannabinoid receptor 1Homo sapiens (human)Ki0.35900.00010.50779.6000AID1546674; AID1674384; AID1845636
Cannabinoid receptor 2 Homo sapiens (human)IC50 (µMol)0.01760.00081.58409.8000AID1674385
Cannabinoid receptor 2 Homo sapiens (human)Ki0.04290.00000.415610.0000AID1625149; AID1674385; AID1845609
Cannabinoid receptor 1Mus musculus (house mouse)Ki0.07500.00060.72467.2000AID1845608
Fatty-acid amide hydrolase 1Rattus norvegicus (Norway rat)Ki0.06300.00060.16192.0000AID1625149
N-acylethanolamine-hydrolyzing acid amidaseHomo sapiens (human)IC50 (µMol)100.00000.70000.70000.7000AID1625159
Transient receptor potential cation channel subfamily M member 8Homo sapiens (human)IC50 (µMol)0.02000.02001.27553.9000AID1845631
Transient receptor potential cation channel subfamily V member 1Homo sapiens (human)IC50 (µMol)1.30000.00020.606010.0000AID1845614
Transient receptor potential cation channel subfamily V member 3Homo sapiens (human)IC50 (µMol)3.00003.00006.20009.4000AID1845620
Transient receptor potential cation channel subfamily V member 6Homo sapiens (human)IC50 (µMol)9.40009.40009.40009.4000AID1845624
Transient receptor potential cation channel subfamily V member 4Homo sapiens (human)IC50 (µMol)3.20000.01802.01349.9000AID1845623
Transient receptor potential cation channel subfamily V member 5Homo sapiens (human)IC50 (µMol)4.80004.80004.80004.8000AID1845597
Diacylglycerol lipase-alphaHomo sapiens (human)IC50 (µMol)50.00000.00101.05385.0119AID1625150
Transient receptor potential cation channel subfamily V member 2Homo sapiens (human)IC50 (µMol)0.80000.80002.93336.5000AID1845617
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Activation Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Transient receptor potential cation channel subfamily A member 1Homo sapiens (human)EC50 (µMol)0.78500.00033.166210.0000AID1845625; AID1845630
5-hydroxytryptamine receptor 1AHomo sapiens (human)EC50 (µMol)0.02800.00010.25718.0000AID1845602
5-hydroxytryptamine receptor 1ARattus norvegicus (Norway rat)EC50 (µMol)0.00540.00543.251020.9400AID1845601
Cannabinoid receptor 2 Homo sapiens (human)EC50 (µMol)0.06800.00030.15173.2800AID1845598; AID1845600
Cannabinoid receptor 1Mus musculus (house mouse)EC50 (µMol)12.70000.15850.28110.5420AID1845596
Transient receptor potential cation channel subfamily V member 1Homo sapiens (human)EC50 (µMol)0.85000.00051.06746.3096AID1845612; AID1845629
Transient receptor potential cation channel subfamily V member 3Homo sapiens (human)EC50 (µMol)3.80001.00002.74005.3000AID1845618
Transient receptor potential cation channel subfamily V member 4Homo sapiens (human)EC50 (µMol)6.40000.04902.60986.4000AID1845621
G-protein coupled receptor 55Homo sapiens (human)EC50 (µMol)0.88000.00200.66622.0100AID1845599
Transient receptor potential cation channel subfamily V member 2Homo sapiens (human)EC50 (µMol)4.10001.70004.36677.3000AID1845615
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Biological Processes (165)

Processvia Protein(s)Taxonomy
monoatomic ion transportTransient receptor potential cation channel subfamily A member 1Homo sapiens (human)
intracellular calcium ion homeostasisTransient receptor potential cation channel subfamily A member 1Homo sapiens (human)
cell surface receptor signaling pathwayTransient receptor potential cation channel subfamily A member 1Homo sapiens (human)
response to coldTransient receptor potential cation channel subfamily A member 1Homo sapiens (human)
response to xenobiotic stimulusTransient receptor potential cation channel subfamily A member 1Homo sapiens (human)
response to organic substanceTransient receptor potential cation channel subfamily A member 1Homo sapiens (human)
response to organic cyclic compoundTransient receptor potential cation channel subfamily A member 1Homo sapiens (human)
sensory perception of painTransient receptor potential cation channel subfamily A member 1Homo sapiens (human)
calcium-mediated signalingTransient receptor potential cation channel subfamily A member 1Homo sapiens (human)
response to painTransient receptor potential cation channel subfamily A member 1Homo sapiens (human)
thermoceptionTransient receptor potential cation channel subfamily A member 1Homo sapiens (human)
detection of mechanical stimulus involved in sensory perception of painTransient receptor potential cation channel subfamily A member 1Homo sapiens (human)
detection of chemical stimulus involved in sensory perception of painTransient receptor potential cation channel subfamily A member 1Homo sapiens (human)
protein homotetramerizationTransient receptor potential cation channel subfamily A member 1Homo sapiens (human)
cellular response to hydrogen peroxideTransient receptor potential cation channel subfamily A member 1Homo sapiens (human)
calcium ion transmembrane transportTransient receptor potential cation channel subfamily A member 1Homo sapiens (human)
cellular response to organic substanceTransient receptor potential cation channel subfamily A member 1Homo sapiens (human)
behavioral fear response5-hydroxytryptamine receptor 1AHomo sapiens (human)
G protein-coupled receptor signaling pathway5-hydroxytryptamine receptor 1AHomo sapiens (human)
adenylate cyclase-inhibiting serotonin receptor signaling pathway5-hydroxytryptamine receptor 1AHomo sapiens (human)
serotonin receptor signaling pathway5-hydroxytryptamine receptor 1AHomo sapiens (human)
gamma-aminobutyric acid signaling pathway5-hydroxytryptamine receptor 1AHomo sapiens (human)
positive regulation of cell population proliferation5-hydroxytryptamine receptor 1AHomo sapiens (human)
regulation of serotonin secretion5-hydroxytryptamine receptor 1AHomo sapiens (human)
regulation of vasoconstriction5-hydroxytryptamine receptor 1AHomo sapiens (human)
exploration behavior5-hydroxytryptamine receptor 1AHomo sapiens (human)
regulation of dopamine metabolic process5-hydroxytryptamine receptor 1AHomo sapiens (human)
serotonin metabolic process5-hydroxytryptamine receptor 1AHomo sapiens (human)
regulation of hormone secretion5-hydroxytryptamine receptor 1AHomo sapiens (human)
regulation of behavior5-hydroxytryptamine receptor 1AHomo sapiens (human)
chemical synaptic transmission5-hydroxytryptamine receptor 1AHomo sapiens (human)
G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger5-hydroxytryptamine receptor 1AHomo sapiens (human)
positive regulation of acute inflammatory response to antigenic stimulusCannabinoid receptor 1Homo sapiens (human)
G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messengerCannabinoid receptor 1Homo sapiens (human)
adenylate cyclase-modulating G protein-coupled receptor signaling pathwayCannabinoid receptor 1Homo sapiens (human)
spermatogenesisCannabinoid receptor 1Homo sapiens (human)
axonal fasciculationCannabinoid receptor 1Homo sapiens (human)
response to nutrientCannabinoid receptor 1Homo sapiens (human)
memoryCannabinoid receptor 1Homo sapiens (human)
positive regulation of neuron projection developmentCannabinoid receptor 1Homo sapiens (human)
negative regulation of serotonin secretionCannabinoid receptor 1Homo sapiens (human)
positive regulation of fever generationCannabinoid receptor 1Homo sapiens (human)
negative regulation of fatty acid beta-oxidationCannabinoid receptor 1Homo sapiens (human)
regulation of synaptic transmission, GABAergicCannabinoid receptor 1Homo sapiens (human)
response to lipopolysaccharideCannabinoid receptor 1Homo sapiens (human)
negative regulation of mast cell activationCannabinoid receptor 1Homo sapiens (human)
negative regulation of dopamine secretionCannabinoid receptor 1Homo sapiens (human)
response to nicotineCannabinoid receptor 1Homo sapiens (human)
cannabinoid signaling pathwayCannabinoid receptor 1Homo sapiens (human)
response to cocaineCannabinoid receptor 1Homo sapiens (human)
glucose homeostasisCannabinoid receptor 1Homo sapiens (human)
positive regulation of apoptotic processCannabinoid receptor 1Homo sapiens (human)
response to ethanolCannabinoid receptor 1Homo sapiens (human)
negative regulation of action potentialCannabinoid receptor 1Homo sapiens (human)
negative regulation of blood pressureCannabinoid receptor 1Homo sapiens (human)
positive regulation of blood pressureCannabinoid receptor 1Homo sapiens (human)
regulation of insulin secretionCannabinoid receptor 1Homo sapiens (human)
regulation of synaptic transmission, glutamatergicCannabinoid receptor 1Homo sapiens (human)
maternal process involved in female pregnancyCannabinoid receptor 1Homo sapiens (human)
regulation of feeding behaviorCannabinoid receptor 1Homo sapiens (human)
regulation of penile erectionCannabinoid receptor 1Homo sapiens (human)
retrograde trans-synaptic signaling by endocannabinoidCannabinoid receptor 1Homo sapiens (human)
regulation of presynaptic cytosolic calcium ion concentrationCannabinoid receptor 1Homo sapiens (human)
trans-synaptic signaling by endocannabinoid, modulating synaptic transmissionCannabinoid receptor 1Homo sapiens (human)
adenylate cyclase-activating G protein-coupled receptor signaling pathwayCannabinoid receptor 1Homo sapiens (human)
regulation of metabolic processCannabinoid receptor 1Homo sapiens (human)
response to amphetamineCannabinoid receptor 2 Homo sapiens (human)
inflammatory responseCannabinoid receptor 2 Homo sapiens (human)
immune responseCannabinoid receptor 2 Homo sapiens (human)
G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messengerCannabinoid receptor 2 Homo sapiens (human)
leukocyte chemotaxisCannabinoid receptor 2 Homo sapiens (human)
negative regulation of synaptic transmission, GABAergicCannabinoid receptor 2 Homo sapiens (human)
response to lipopolysaccharideCannabinoid receptor 2 Homo sapiens (human)
negative regulation of mast cell activationCannabinoid receptor 2 Homo sapiens (human)
cannabinoid signaling pathwayCannabinoid receptor 2 Homo sapiens (human)
negative regulation of action potentialCannabinoid receptor 2 Homo sapiens (human)
regulation of metabolic processCannabinoid receptor 2 Homo sapiens (human)
adenylate cyclase-activating G protein-coupled receptor signaling pathwayCannabinoid receptor 2 Homo sapiens (human)
fatty acid metabolic processN-acylethanolamine-hydrolyzing acid amidaseHomo sapiens (human)
sphingosine metabolic processN-acylethanolamine-hydrolyzing acid amidaseHomo sapiens (human)
lipid catabolic processN-acylethanolamine-hydrolyzing acid amidaseHomo sapiens (human)
N-acylethanolamine metabolic processN-acylethanolamine-hydrolyzing acid amidaseHomo sapiens (human)
N-acylphosphatidylethanolamine metabolic processN-acylethanolamine-hydrolyzing acid amidaseHomo sapiens (human)
intracellular calcium ion homeostasisTransient receptor potential cation channel subfamily M member 8Homo sapiens (human)
response to coldTransient receptor potential cation channel subfamily M member 8Homo sapiens (human)
calcium-mediated signalingTransient receptor potential cation channel subfamily M member 8Homo sapiens (human)
thermoceptionTransient receptor potential cation channel subfamily M member 8Homo sapiens (human)
calcium ion transmembrane transportTransient receptor potential cation channel subfamily M member 8Homo sapiens (human)
positive regulation of cold-induced thermogenesisTransient receptor potential cation channel subfamily M member 8Homo sapiens (human)
thermoceptionTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
negative regulation of transcription by RNA polymerase IITransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
fever generationTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
microglial cell activationTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
diet induced thermogenesisTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
peptide secretionTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
negative regulation of systemic arterial blood pressureTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
lipid metabolic processTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
cell surface receptor signaling pathwayTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
positive regulation of cytosolic calcium ion concentrationTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
chemosensory behaviorTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
negative regulation of heart rateTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
negative regulation of mitochondrial membrane potentialTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
glutamate secretionTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
calcium-mediated signalingTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
cellular response to heatTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
positive regulation of apoptotic processTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
response to peptide hormoneTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
positive regulation of nitric oxide biosynthetic processTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
behavioral response to painTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
sensory perception of mechanical stimulusTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
detection of temperature stimulus involved in thermoceptionTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
detection of temperature stimulus involved in sensory perception of painTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
detection of chemical stimulus involved in sensory perception of painTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
protein homotetramerizationTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
excitatory postsynaptic potentialTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
smooth muscle contraction involved in micturitionTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
calcium ion transmembrane transportTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
cellular response to alkaloidTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
cellular response to ATPTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
cellular response to tumor necrosis factorTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
cellular response to acidic pHTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
cellular response to temperature stimulusTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
negative regulation of establishment of blood-brain barrierTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
calcium ion import across plasma membraneTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
response to capsazepineTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
cellular response to nerve growth factor stimulusTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
response to temperature stimulusTransient receptor potential cation channel subfamily V member 3Homo sapiens (human)
negative regulation of hair cycleTransient receptor potential cation channel subfamily V member 3Homo sapiens (human)
calcium ion transmembrane transportTransient receptor potential cation channel subfamily V member 3Homo sapiens (human)
positive regulation of calcium ion importTransient receptor potential cation channel subfamily V member 3Homo sapiens (human)
calcium ion import across plasma membraneTransient receptor potential cation channel subfamily V member 3Homo sapiens (human)
calcium ion transportTransient receptor potential cation channel subfamily V member 6Homo sapiens (human)
regulation of calcium ion-dependent exocytosisTransient receptor potential cation channel subfamily V member 6Homo sapiens (human)
parathyroid hormone secretionTransient receptor potential cation channel subfamily V member 6Homo sapiens (human)
response to calcium ionTransient receptor potential cation channel subfamily V member 6Homo sapiens (human)
calcium ion homeostasisTransient receptor potential cation channel subfamily V member 6Homo sapiens (human)
calcium ion transmembrane transportTransient receptor potential cation channel subfamily V member 6Homo sapiens (human)
calcium ion import across plasma membraneTransient receptor potential cation channel subfamily V member 6Homo sapiens (human)
negative regulation of transcription by RNA polymerase IITransient receptor potential cation channel subfamily V member 4Homo sapiens (human)
response to hypoxiaTransient receptor potential cation channel subfamily V member 4Homo sapiens (human)
diet induced thermogenesisTransient receptor potential cation channel subfamily V member 4Homo sapiens (human)
calcium ion transportTransient receptor potential cation channel subfamily V member 4Homo sapiens (human)
intracellular calcium ion homeostasisTransient receptor potential cation channel subfamily V member 4Homo sapiens (human)
cell volume homeostasisTransient receptor potential cation channel subfamily V member 4Homo sapiens (human)
actin filament organizationTransient receptor potential cation channel subfamily V member 4Homo sapiens (human)
cell-cell junction assemblyTransient receptor potential cation channel subfamily V member 4Homo sapiens (human)
positive regulation of cytosolic calcium ion concentrationTransient receptor potential cation channel subfamily V member 4Homo sapiens (human)
osmosensory signaling pathwayTransient receptor potential cation channel subfamily V member 4Homo sapiens (human)
response to mechanical stimulusTransient receptor potential cation channel subfamily V member 4Homo sapiens (human)
positive regulation of macrophage chemotaxisTransient receptor potential cation channel subfamily V member 4Homo sapiens (human)
negative regulation of neuron projection developmentTransient receptor potential cation channel subfamily V member 4Homo sapiens (human)
actin cytoskeleton organizationTransient receptor potential cation channel subfamily V member 4Homo sapiens (human)
vasopressin secretionTransient receptor potential cation channel subfamily V member 4Homo sapiens (human)
positive regulation of microtubule depolymerizationTransient receptor potential cation channel subfamily V member 4Homo sapiens (human)
positive regulation of interleukin-6 productionTransient receptor potential cation channel subfamily V member 4Homo sapiens (human)
response to insulinTransient receptor potential cation channel subfamily V member 4Homo sapiens (human)
cellular response to heatTransient receptor potential cation channel subfamily V member 4Homo sapiens (human)
hyperosmotic salinity responseTransient receptor potential cation channel subfamily V member 4Homo sapiens (human)
glucose homeostasisTransient receptor potential cation channel subfamily V member 4Homo sapiens (human)
positive regulation of vascular permeabilityTransient receptor potential cation channel subfamily V member 4Homo sapiens (human)
cortical microtubule organizationTransient receptor potential cation channel subfamily V member 4Homo sapiens (human)
positive regulation of striated muscle contractionTransient receptor potential cation channel subfamily V member 4Homo sapiens (human)
positive regulation of JNK cascadeTransient receptor potential cation channel subfamily V member 4Homo sapiens (human)
microtubule polymerizationTransient receptor potential cation channel subfamily V member 4Homo sapiens (human)
regulation of response to osmotic stressTransient receptor potential cation channel subfamily V member 4Homo sapiens (human)
positive regulation of inflammatory responseTransient receptor potential cation channel subfamily V member 4Homo sapiens (human)
multicellular organismal-level water homeostasisTransient receptor potential cation channel subfamily V member 4Homo sapiens (human)
cartilage development involved in endochondral bone morphogenesisTransient receptor potential cation channel subfamily V member 4Homo sapiens (human)
positive regulation of ERK1 and ERK2 cascadeTransient receptor potential cation channel subfamily V member 4Homo sapiens (human)
calcium ion importTransient receptor potential cation channel subfamily V member 4Homo sapiens (human)
calcium ion transmembrane transportTransient receptor potential cation channel subfamily V member 4Homo sapiens (human)
cellular response to osmotic stressTransient receptor potential cation channel subfamily V member 4Homo sapiens (human)
cellular hypotonic responseTransient receptor potential cation channel subfamily V member 4Homo sapiens (human)
cellular hypotonic salinity responseTransient receptor potential cation channel subfamily V member 4Homo sapiens (human)
positive regulation of monocyte chemotactic protein-1 productionTransient receptor potential cation channel subfamily V member 4Homo sapiens (human)
positive regulation of macrophage inflammatory protein 1 alpha productionTransient receptor potential cation channel subfamily V member 4Homo sapiens (human)
positive regulation of chemokine (C-C motif) ligand 5 productionTransient receptor potential cation channel subfamily V member 4Homo sapiens (human)
blood vessel endothelial cell delaminationTransient receptor potential cation channel subfamily V member 4Homo sapiens (human)
calcium ion import into cytosolTransient receptor potential cation channel subfamily V member 4Homo sapiens (human)
negative regulation of brown fat cell differentiationTransient receptor potential cation channel subfamily V member 4Homo sapiens (human)
regulation of aerobic respirationTransient receptor potential cation channel subfamily V member 4Homo sapiens (human)
positive regulation of chemokine (C-X-C motif) ligand 1 productionTransient receptor potential cation channel subfamily V member 4Homo sapiens (human)
calcium ion import across plasma membraneTransient receptor potential cation channel subfamily V member 4Homo sapiens (human)
calcium ion transportTransient receptor potential cation channel subfamily V member 5Homo sapiens (human)
regulation of urine volumeTransient receptor potential cation channel subfamily V member 5Homo sapiens (human)
protein homotetramerizationTransient receptor potential cation channel subfamily V member 5Homo sapiens (human)
calcium ion homeostasisTransient receptor potential cation channel subfamily V member 5Homo sapiens (human)
calcium ion transmembrane transportTransient receptor potential cation channel subfamily V member 5Homo sapiens (human)
calcium ion import across plasma membraneTransient receptor potential cation channel subfamily V member 5Homo sapiens (human)
G protein-coupled receptor signaling pathwayG-protein coupled receptor 55Homo sapiens (human)
activation of phospholipase C activityG-protein coupled receptor 55Homo sapiens (human)
positive regulation of Rho protein signal transductionG-protein coupled receptor 55Homo sapiens (human)
cannabinoid signaling pathwayG-protein coupled receptor 55Homo sapiens (human)
bone resorptionG-protein coupled receptor 55Homo sapiens (human)
negative regulation of osteoclast differentiationG-protein coupled receptor 55Homo sapiens (human)
positive regulation of ERK1 and ERK2 cascadeG-protein coupled receptor 55Homo sapiens (human)
phospholipase C-activating G protein-coupled receptor signaling pathwayG-protein coupled receptor 55Homo sapiens (human)
monoacylglycerol biosynthetic processDiacylglycerol lipase-alphaHomo sapiens (human)
G protein-coupled glutamate receptor signaling pathwayDiacylglycerol lipase-alphaHomo sapiens (human)
neuroblast proliferationDiacylglycerol lipase-alphaHomo sapiens (human)
arachidonic acid metabolic processDiacylglycerol lipase-alphaHomo sapiens (human)
diacylglycerol catabolic processDiacylglycerol lipase-alphaHomo sapiens (human)
retrograde trans-synaptic signaling by endocannabinoidDiacylglycerol lipase-alphaHomo sapiens (human)
regulation of neuroinflammatory responseDiacylglycerol lipase-alphaHomo sapiens (human)
cannabinoid biosynthetic processDiacylglycerol lipase-alphaHomo sapiens (human)
response to temperature stimulusTransient receptor potential cation channel subfamily V member 2Homo sapiens (human)
sensory perceptionTransient receptor potential cation channel subfamily V member 2Homo sapiens (human)
positive regulation of axon extensionTransient receptor potential cation channel subfamily V member 2Homo sapiens (human)
calcium ion transmembrane transportTransient receptor potential cation channel subfamily V member 2Homo sapiens (human)
positive regulation of calcium ion importTransient receptor potential cation channel subfamily V member 2Homo sapiens (human)
positive regulation of cold-induced thermogenesisTransient receptor potential cation channel subfamily V member 2Homo sapiens (human)
calcium ion import across plasma membraneTransient receptor potential cation channel subfamily V member 2Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Molecular Functions (46)

Processvia Protein(s)Taxonomy
calcium channel activityTransient receptor potential cation channel subfamily A member 1Homo sapiens (human)
channel activityTransient receptor potential cation channel subfamily A member 1Homo sapiens (human)
intracellularly gated calcium channel activityTransient receptor potential cation channel subfamily A member 1Homo sapiens (human)
identical protein bindingTransient receptor potential cation channel subfamily A member 1Homo sapiens (human)
temperature-gated cation channel activityTransient receptor potential cation channel subfamily A member 1Homo sapiens (human)
G protein-coupled serotonin receptor activity5-hydroxytryptamine receptor 1AHomo sapiens (human)
protein binding5-hydroxytryptamine receptor 1AHomo sapiens (human)
receptor-receptor interaction5-hydroxytryptamine receptor 1AHomo sapiens (human)
neurotransmitter receptor activity5-hydroxytryptamine receptor 1AHomo sapiens (human)
serotonin binding5-hydroxytryptamine receptor 1AHomo sapiens (human)
cannabinoid receptor activityCannabinoid receptor 1Homo sapiens (human)
protein bindingCannabinoid receptor 1Homo sapiens (human)
identical protein bindingCannabinoid receptor 1Homo sapiens (human)
G protein-coupled receptor activityCannabinoid receptor 1Homo sapiens (human)
protein bindingCannabinoid receptor 2 Homo sapiens (human)
cannabinoid receptor activityCannabinoid receptor 2 Homo sapiens (human)
hydrolase activity, acting on carbon-nitrogen (but not peptide) bondsN-acylethanolamine-hydrolyzing acid amidaseHomo sapiens (human)
N-acylsphingosine amidohydrolase activityN-acylethanolamine-hydrolyzing acid amidaseHomo sapiens (human)
fatty acid amide hydrolase activityN-acylethanolamine-hydrolyzing acid amidaseHomo sapiens (human)
N-(long-chain-acyl)ethanolamine deacylase activityN-acylethanolamine-hydrolyzing acid amidaseHomo sapiens (human)
ceramidase activityN-acylethanolamine-hydrolyzing acid amidaseHomo sapiens (human)
DNA-binding transcription factor bindingN-acylethanolamine-hydrolyzing acid amidaseHomo sapiens (human)
calcium channel activityTransient receptor potential cation channel subfamily M member 8Homo sapiens (human)
protein bindingTransient receptor potential cation channel subfamily M member 8Homo sapiens (human)
identical protein bindingTransient receptor potential cation channel subfamily M member 8Homo sapiens (human)
ligand-gated calcium channel activityTransient receptor potential cation channel subfamily M member 8Homo sapiens (human)
transmembrane signaling receptor activityTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
extracellular ligand-gated monoatomic ion channel activityTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
excitatory extracellular ligand-gated monoatomic ion channel activityTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
voltage-gated calcium channel activityTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
calcium channel activityTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
protein bindingTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
calmodulin bindingTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
ATP bindingTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
intracellularly gated calcium channel activityTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
chloride channel regulator activityTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
phosphatidylinositol bindingTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
identical protein bindingTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
metal ion bindingTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
phosphoprotein bindingTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
temperature-gated ion channel activityTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
calcium channel activityTransient receptor potential cation channel subfamily V member 3Homo sapiens (human)
protein bindingTransient receptor potential cation channel subfamily V member 3Homo sapiens (human)
calcium channel activityTransient receptor potential cation channel subfamily V member 6Homo sapiens (human)
protein bindingTransient receptor potential cation channel subfamily V member 6Homo sapiens (human)
calmodulin bindingTransient receptor potential cation channel subfamily V member 6Homo sapiens (human)
identical protein bindingTransient receptor potential cation channel subfamily V member 6Homo sapiens (human)
metal ion bindingTransient receptor potential cation channel subfamily V member 6Homo sapiens (human)
actin bindingTransient receptor potential cation channel subfamily V member 4Homo sapiens (human)
osmosensor activityTransient receptor potential cation channel subfamily V member 4Homo sapiens (human)
protein kinase C bindingTransient receptor potential cation channel subfamily V member 4Homo sapiens (human)
monoatomic cation channel activityTransient receptor potential cation channel subfamily V member 4Homo sapiens (human)
calcium channel activityTransient receptor potential cation channel subfamily V member 4Homo sapiens (human)
protein bindingTransient receptor potential cation channel subfamily V member 4Homo sapiens (human)
calmodulin bindingTransient receptor potential cation channel subfamily V member 4Homo sapiens (human)
ATP bindingTransient receptor potential cation channel subfamily V member 4Homo sapiens (human)
microtubule bindingTransient receptor potential cation channel subfamily V member 4Homo sapiens (human)
lipid bindingTransient receptor potential cation channel subfamily V member 4Homo sapiens (human)
stretch-activated, monoatomic cation-selective, calcium channel activityTransient receptor potential cation channel subfamily V member 4Homo sapiens (human)
protein kinase bindingTransient receptor potential cation channel subfamily V member 4Homo sapiens (human)
SH2 domain bindingTransient receptor potential cation channel subfamily V member 4Homo sapiens (human)
identical protein bindingTransient receptor potential cation channel subfamily V member 4Homo sapiens (human)
alpha-tubulin bindingTransient receptor potential cation channel subfamily V member 4Homo sapiens (human)
metal ion bindingTransient receptor potential cation channel subfamily V member 4Homo sapiens (human)
beta-tubulin bindingTransient receptor potential cation channel subfamily V member 4Homo sapiens (human)
actin filament bindingTransient receptor potential cation channel subfamily V member 4Homo sapiens (human)
calcium channel activityTransient receptor potential cation channel subfamily V member 5Homo sapiens (human)
protein bindingTransient receptor potential cation channel subfamily V member 5Homo sapiens (human)
calmodulin bindingTransient receptor potential cation channel subfamily V member 5Homo sapiens (human)
metal ion bindingTransient receptor potential cation channel subfamily V member 5Homo sapiens (human)
G protein-coupled receptor activityG-protein coupled receptor 55Homo sapiens (human)
cannabinoid receptor activityG-protein coupled receptor 55Homo sapiens (human)
protein bindingDiacylglycerol lipase-alphaHomo sapiens (human)
metal ion bindingDiacylglycerol lipase-alphaHomo sapiens (human)
acylglycerol lipase activityDiacylglycerol lipase-alphaHomo sapiens (human)
lipoprotein lipase activityDiacylglycerol lipase-alphaHomo sapiens (human)
monoatomic ion channel activityTransient receptor potential cation channel subfamily V member 2Homo sapiens (human)
monoatomic cation channel activityTransient receptor potential cation channel subfamily V member 2Homo sapiens (human)
calcium channel activityTransient receptor potential cation channel subfamily V member 2Homo sapiens (human)
protein bindingTransient receptor potential cation channel subfamily V member 2Homo sapiens (human)
monoatomic ion transmembrane transporter activityTransient receptor potential cation channel subfamily V member 2Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (44)

Processvia Protein(s)Taxonomy
plasma membraneTransient receptor potential cation channel subfamily A member 1Homo sapiens (human)
stereocilium bundleTransient receptor potential cation channel subfamily A member 1Homo sapiens (human)
plasma membrane5-hydroxytryptamine receptor 1AHomo sapiens (human)
synapse5-hydroxytryptamine receptor 1AHomo sapiens (human)
plasma membrane5-hydroxytryptamine receptor 1AHomo sapiens (human)
dendrite5-hydroxytryptamine receptor 1AHomo sapiens (human)
mitochondrial outer membraneCannabinoid receptor 1Homo sapiens (human)
plasma membraneCannabinoid receptor 1Homo sapiens (human)
actin cytoskeletonCannabinoid receptor 1Homo sapiens (human)
growth coneCannabinoid receptor 1Homo sapiens (human)
presynaptic membraneCannabinoid receptor 1Homo sapiens (human)
membrane raftCannabinoid receptor 1Homo sapiens (human)
glutamatergic synapseCannabinoid receptor 1Homo sapiens (human)
GABA-ergic synapseCannabinoid receptor 1Homo sapiens (human)
plasma membraneCannabinoid receptor 1Homo sapiens (human)
cytoplasmCannabinoid receptor 1Homo sapiens (human)
plasma membraneCannabinoid receptor 2 Homo sapiens (human)
dendriteCannabinoid receptor 2 Homo sapiens (human)
extrinsic component of cytoplasmic side of plasma membraneCannabinoid receptor 2 Homo sapiens (human)
perikaryonCannabinoid receptor 2 Homo sapiens (human)
endoplasmic reticulumCannabinoid receptor 2 Homo sapiens (human)
plasma membraneCannabinoid receptor 2 Homo sapiens (human)
cytoplasmCannabinoid receptor 2 Homo sapiens (human)
cytoplasmN-acylethanolamine-hydrolyzing acid amidaseHomo sapiens (human)
lysosomeN-acylethanolamine-hydrolyzing acid amidaseHomo sapiens (human)
membraneN-acylethanolamine-hydrolyzing acid amidaseHomo sapiens (human)
lysosomal lumenN-acylethanolamine-hydrolyzing acid amidaseHomo sapiens (human)
extracellular exosomeN-acylethanolamine-hydrolyzing acid amidaseHomo sapiens (human)
endoplasmic reticulum membraneTransient receptor potential cation channel subfamily M member 8Homo sapiens (human)
plasma membraneTransient receptor potential cation channel subfamily M member 8Homo sapiens (human)
external side of plasma membraneTransient receptor potential cation channel subfamily M member 8Homo sapiens (human)
membrane raftTransient receptor potential cation channel subfamily M member 8Homo sapiens (human)
plasma membraneTransient receptor potential cation channel subfamily M member 8Homo sapiens (human)
plasma membraneTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
external side of plasma membraneTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
membraneTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
dendritic spine membraneTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
neuronal cell bodyTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
postsynaptic membraneTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
plasma membraneTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
cytoplasmTransient receptor potential cation channel subfamily V member 3Homo sapiens (human)
lysosomeTransient receptor potential cation channel subfamily V member 3Homo sapiens (human)
plasma membraneTransient receptor potential cation channel subfamily V member 3Homo sapiens (human)
receptor complexTransient receptor potential cation channel subfamily V member 3Homo sapiens (human)
plasma membraneTransient receptor potential cation channel subfamily V member 3Homo sapiens (human)
plasma membraneTransient receptor potential cation channel subfamily V member 6Homo sapiens (human)
calcium channel complexTransient receptor potential cation channel subfamily V member 6Homo sapiens (human)
plasma membraneTransient receptor potential cation channel subfamily V member 6Homo sapiens (human)
cytoplasmic microtubuleTransient receptor potential cation channel subfamily V member 4Homo sapiens (human)
endoplasmic reticulumTransient receptor potential cation channel subfamily V member 4Homo sapiens (human)
plasma membraneTransient receptor potential cation channel subfamily V member 4Homo sapiens (human)
adherens junctionTransient receptor potential cation channel subfamily V member 4Homo sapiens (human)
focal adhesionTransient receptor potential cation channel subfamily V member 4Homo sapiens (human)
ciliumTransient receptor potential cation channel subfamily V member 4Homo sapiens (human)
cell surfaceTransient receptor potential cation channel subfamily V member 4Homo sapiens (human)
membraneTransient receptor potential cation channel subfamily V member 4Homo sapiens (human)
apical plasma membraneTransient receptor potential cation channel subfamily V member 4Homo sapiens (human)
lamellipodiumTransient receptor potential cation channel subfamily V member 4Homo sapiens (human)
filopodiumTransient receptor potential cation channel subfamily V member 4Homo sapiens (human)
growth coneTransient receptor potential cation channel subfamily V member 4Homo sapiens (human)
cortical actin cytoskeletonTransient receptor potential cation channel subfamily V member 4Homo sapiens (human)
ruffle membraneTransient receptor potential cation channel subfamily V member 4Homo sapiens (human)
plasma membraneTransient receptor potential cation channel subfamily V member 4Homo sapiens (human)
ciliumTransient receptor potential cation channel subfamily V member 4Homo sapiens (human)
plasma membraneTransient receptor potential cation channel subfamily V member 5Homo sapiens (human)
apical plasma membraneTransient receptor potential cation channel subfamily V member 5Homo sapiens (human)
plasma membraneTransient receptor potential cation channel subfamily V member 5Homo sapiens (human)
plasma membraneG-protein coupled receptor 55Homo sapiens (human)
plasma membraneG-protein coupled receptor 55Homo sapiens (human)
plasma membraneDiacylglycerol lipase-alphaHomo sapiens (human)
early endosome membraneDiacylglycerol lipase-alphaHomo sapiens (human)
dendrite membraneDiacylglycerol lipase-alphaHomo sapiens (human)
dendritic spine membraneDiacylglycerol lipase-alphaHomo sapiens (human)
varicosityDiacylglycerol lipase-alphaHomo sapiens (human)
postsynaptic density membraneDiacylglycerol lipase-alphaHomo sapiens (human)
dendrite membraneDiacylglycerol lipase-alphaHomo sapiens (human)
cytoplasmDiacylglycerol lipase-alphaHomo sapiens (human)
postsynaptic membraneDiacylglycerol lipase-alphaHomo sapiens (human)
plasma membraneTransient receptor potential cation channel subfamily V member 2Homo sapiens (human)
cell surfaceTransient receptor potential cation channel subfamily V member 2Homo sapiens (human)
growth cone membraneTransient receptor potential cation channel subfamily V member 2Homo sapiens (human)
melanosomeTransient receptor potential cation channel subfamily V member 2Homo sapiens (human)
axonal growth coneTransient receptor potential cation channel subfamily V member 2Homo sapiens (human)
cell bodyTransient receptor potential cation channel subfamily V member 2Homo sapiens (human)
plasma membraneTransient receptor potential cation channel subfamily V member 2Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (67)

Assay IDTitleYearJournalArticle
AID1845623Agonist activity at ionomycin-stimulated TRPV4 (unknown origin) channel desensitization in presence of 4alphaPDD2021Journal of natural products, 01-22, Volume: 84, Issue:1
Phytocannabinoid Pharmacology: Medicinal Properties of
AID750722Antagonist activity at human GPR55 expressed in HEK293 cells assessed as inhibition of LPI-induced beta-arrestin recruitment incubated 60 mins prior to LPI addition by beta-arrestin translocation assay2013Journal of medicinal chemistry, Jun-13, Volume: 56, Issue:11
Antagonists for the orphan G-protein-coupled receptor GPR55 based on a coumarin scaffold.
AID1524912Cytotoxicity against human PC3 cells assessed as reduction in cell viability incubated for 24 to 72 hrs by MTT assay2019Bioorganic & medicinal chemistry letters, 05-01, Volume: 29, Issue:9
Analyzing the role of cannabinoids as modulators of Wnt/β-catenin signaling pathway for their use in the management of neuropathic pain.
AID1845628Agonist activity at TRPA1 (unknown origin) channel desensitization in presence of icilin2021Journal of natural products, 01-22, Volume: 84, Issue:1
Phytocannabinoid Pharmacology: Medicinal Properties of
AID1845601Displacement of [35S]GTPgammaS from 5HT1A in Sprague-Dawley rat brainstem incubated for 60 mins by radioligand binding assay2021Journal of natural products, 01-22, Volume: 84, Issue:1
Phytocannabinoid Pharmacology: Medicinal Properties of
AID1845614Agonist activity at ionomycin-stimulated TRPV1 (unknown origin) channel desensitization in presence of capsaicin2021Journal of natural products, 01-22, Volume: 84, Issue:1
Phytocannabinoid Pharmacology: Medicinal Properties of
AID1845629Agonist activity at TRPV1 (unknown origin) ion channel2021Journal of natural products, 01-22, Volume: 84, Issue:1
Phytocannabinoid Pharmacology: Medicinal Properties of
AID1625148Displacement of [3H]-CP55940 from CB1 receptor in mouse whole brain membrane measured after 60 mins by liquid scintillation counting method2019Journal of natural products, 03-22, Volume: 82, Issue:3
Plant-Based Modulators of Endocannabinoid Signaling.
AID1524902Cytotoxicity against human OVCAR cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay2019Bioorganic & medicinal chemistry letters, 05-01, Volume: 29, Issue:9
Analyzing the role of cannabinoids as modulators of Wnt/β-catenin signaling pathway for their use in the management of neuropathic pain.
AID1524908Cytotoxicity against human HCT116 cells assessed as reduction in cell viability incubated for 24 to 72 hrs by MTT assay2019Bioorganic & medicinal chemistry letters, 05-01, Volume: 29, Issue:9
Analyzing the role of cannabinoids as modulators of Wnt/β-catenin signaling pathway for their use in the management of neuropathic pain.
AID1845615Agonist activity at ionomycin-stimulated TRPV2 (unknown origin) activation2021Journal of natural products, 01-22, Volume: 84, Issue:1
Phytocannabinoid Pharmacology: Medicinal Properties of
AID1524904Cytotoxicity against human MCF7 cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay2019Bioorganic & medicinal chemistry letters, 05-01, Volume: 29, Issue:9
Analyzing the role of cannabinoids as modulators of Wnt/β-catenin signaling pathway for their use in the management of neuropathic pain.
AID1845619Agonist activity at ionomycin-stimulated TRPV3 (unknown origin) activation assessed as efficacy relative to control2021Journal of natural products, 01-22, Volume: 84, Issue:1
Phytocannabinoid Pharmacology: Medicinal Properties of
AID1845602Displacement of [35S]GTPgammaS from 5HT1A in human CHO cells incubated for 60 mins by radioligand binding assay2021Journal of natural products, 01-22, Volume: 84, Issue:1
Phytocannabinoid Pharmacology: Medicinal Properties of
AID1524916Inhibition of Wnt/beta-catenin signaling pathway in human HepG2 cells assessed as reduction in TCF-dependent beta-catenin mediated transcription at 20 to 40 uM incubated for 24 hrs by Topflash reporter assay2019Bioorganic & medicinal chemistry letters, 05-01, Volume: 29, Issue:9
Analyzing the role of cannabinoids as modulators of Wnt/β-catenin signaling pathway for their use in the management of neuropathic pain.
AID1524906Cytotoxicity against human HepG2 cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay2019Bioorganic & medicinal chemistry letters, 05-01, Volume: 29, Issue:9
Analyzing the role of cannabinoids as modulators of Wnt/β-catenin signaling pathway for their use in the management of neuropathic pain.
AID1845618Agonist activity at ionomycin-stimulated TRPV3 (unknown origin) activation2021Journal of natural products, 01-22, Volume: 84, Issue:1
Phytocannabinoid Pharmacology: Medicinal Properties of
AID1845605Displacement of [35S]GTPgammaS from 5HT1A in Sprague-Dawley rat brainstem by measuring efficacy incubated for 60 mins by radioligand binding assay relative to control2021Journal of natural products, 01-22, Volume: 84, Issue:1
Phytocannabinoid Pharmacology: Medicinal Properties of
AID1524901Cytotoxicity against human HCT116 cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay2019Bioorganic & medicinal chemistry letters, 05-01, Volume: 29, Issue:9
Analyzing the role of cannabinoids as modulators of Wnt/β-catenin signaling pathway for their use in the management of neuropathic pain.
AID1674384Displacement of [3H]-CP-55,940 from recombinant human CB1R expressed in HEK293 cell membranes after 90 mins2020Journal of natural products, 07-24, Volume: 83, Issue:7
Synthesis of the Major Mammalian Metabolites of THCV.
AID1845596Agonist activity at CB1 receptor in albino MF1 mouse vas deferens assessed as inhibition of electrically evoked vas deferens contraction by incubated for 13 mins followed by electrical stimulation for 2 mins2021Journal of natural products, 01-22, Volume: 84, Issue:1
Phytocannabinoid Pharmacology: Medicinal Properties of
AID1524913Cytotoxicity against human HepG2 cells assessed as reduction in cell viability incubated for 24 to 72 hrs by MTT assay2019Bioorganic & medicinal chemistry letters, 05-01, Volume: 29, Issue:9
Analyzing the role of cannabinoids as modulators of Wnt/β-catenin signaling pathway for their use in the management of neuropathic pain.
AID1845622Agonist activity at ionomycin-stimulated TRPV4 (unknown origin) activation assessed as efficacy relative to control2021Journal of natural products, 01-22, Volume: 84, Issue:1
Phytocannabinoid Pharmacology: Medicinal Properties of
AID1625150Inhibition of recombinant human DAGLalpha expressed in COS7 cells using [14C]-oleoyl-2-arachidonoyl-glycerol as substrate measured after 20 mins by beta-counting method2019Journal of natural products, 03-22, Volume: 82, Issue:3
Plant-Based Modulators of Endocannabinoid Signaling.
AID1625151Inhibition of recombinant human DAGLalpha expressed in COS7 cells at 50 uM using [14C]-oleoyl-2-arachidonoyl-glycerol as substrate measured after 20 mins by beta-counting method relative to control2019Journal of natural products, 03-22, Volume: 82, Issue:3
Plant-Based Modulators of Endocannabinoid Signaling.
AID1845608Displacement of [3H]CP55940 from mouse brain membrane CB1 receptor assessed as inhibition constant2021Journal of natural products, 01-22, Volume: 84, Issue:1
Phytocannabinoid Pharmacology: Medicinal Properties of
AID1524909Cytotoxicity against human OVCAR cells assessed as reduction in cell viability incubated for 24 to 72 hrs by MTT assay2019Bioorganic & medicinal chemistry letters, 05-01, Volume: 29, Issue:9
Analyzing the role of cannabinoids as modulators of Wnt/β-catenin signaling pathway for their use in the management of neuropathic pain.
AID1625159Inhibition of recombinant human NAAA expressed in HEK293 cells using [14C]-N-palmitoylethanolamine as substrate measured after 30 mins by beta-counting method2019Journal of natural products, 03-22, Volume: 82, Issue:3
Plant-Based Modulators of Endocannabinoid Signaling.
AID1845612Agonist activity at ionomycin-stimulated TRPV1 (unknown origin) activation2021Journal of natural products, 01-22, Volume: 84, Issue:1
Phytocannabinoid Pharmacology: Medicinal Properties of
AID1845598Agonist activity at CB2 receptor (unknown origin) expressed in CHO cell membranes assessed as increase in [35S]GTPgammaS binding incubated for 60 mins by liquid scintillation spectrometry analysis2021Journal of natural products, 01-22, Volume: 84, Issue:1
Phytocannabinoid Pharmacology: Medicinal Properties of
AID1625153Inhibition of MAGL in African green monkey COS cell homogenates using [3H]-arachidonoylglycerol as substrate measured after 20 mins by scintillation counting method2019Journal of natural products, 03-22, Volume: 82, Issue:3
Plant-Based Modulators of Endocannabinoid Signaling.
AID1625149Displacement of [3H]-CP55940 from recombinant human CB2 receptor expressed in CHO cell membranes measured after 60 mins by liquid scintillation counting method2019Journal of natural products, 03-22, Volume: 82, Issue:3
Plant-Based Modulators of Endocannabinoid Signaling.
AID1845624Inhibition of TRPV6 channel (unknown origin) by Patch-clamp assay2021Journal of natural products, 01-22, Volume: 84, Issue:1
Phytocannabinoid Pharmacology: Medicinal Properties of
AID1845630Agonist activity at TRPA1 (unknown origin) ion channel2021Journal of natural products, 01-22, Volume: 84, Issue:1
Phytocannabinoid Pharmacology: Medicinal Properties of
AID1625156Inhibition of FAAH in rat brain membranes using [14C]-AEA as substrate measured after 30 mins by scintillation counting method2019Journal of natural products, 03-22, Volume: 82, Issue:3
Plant-Based Modulators of Endocannabinoid Signaling.
AID1524907Cytotoxicity against human SH-SY5Y cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay2019Bioorganic & medicinal chemistry letters, 05-01, Volume: 29, Issue:9
Analyzing the role of cannabinoids as modulators of Wnt/β-catenin signaling pathway for their use in the management of neuropathic pain.
AID1845607Inhibition of human CB2 receptor2021Journal of natural products, 01-22, Volume: 84, Issue:1
Phytocannabinoid Pharmacology: Medicinal Properties of
AID1674385Displacement of [3H]-CP-55,940 from recombinant human CB2R expressed in HEK293 cell membranes after 90 mins2020Journal of natural products, 07-24, Volume: 83, Issue:7
Synthesis of the Major Mammalian Metabolites of THCV.
AID1845609Displacement of [3H]CP55940 from human CB2 receptor transfected in CHO cells assessed as inhibition constant2021Journal of natural products, 01-22, Volume: 84, Issue:1
Phytocannabinoid Pharmacology: Medicinal Properties of
AID1845625Agonist activity at TRPA1 (unknown origin) activation2021Journal of natural products, 01-22, Volume: 84, Issue:1
Phytocannabinoid Pharmacology: Medicinal Properties of
AID1845636Binding affinity to CB1 (unknown origin) receptor assessed as inhibition constant2021Journal of natural products, 01-22, Volume: 84, Issue:1
Phytocannabinoid Pharmacology: Medicinal Properties of
AID1845599Antagonist activity at GPR55 (unknown origin) expressed in HEK293 cells assessed as LPI-stimulated ERK1/2 phosphorylation2021Journal of natural products, 01-22, Volume: 84, Issue:1
Phytocannabinoid Pharmacology: Medicinal Properties of
AID1845631Antagonist activity at TRPM8 (unknown origin) ion channel2021Journal of natural products, 01-22, Volume: 84, Issue:1
Phytocannabinoid Pharmacology: Medicinal Properties of
AID1625158Inhibition of FAAH in rat brain membranes at 100 uM using [14C]-AEA as substrate measured after 30 mins by scintillation counting method relative to control2019Journal of natural products, 03-22, Volume: 82, Issue:3
Plant-Based Modulators of Endocannabinoid Signaling.
AID1625162Inhibition of [14C]-AEA uptake in rat RBL2H3 cells by scintillation counting method2019Journal of natural products, 03-22, Volume: 82, Issue:3
Plant-Based Modulators of Endocannabinoid Signaling.
AID1845603Agonist activity at CB2 receptor (unknown origin) expressed in CHO cell membranes assessed as increase in [35S]GTPgammaS binding by measuring efficacy incubated for 60 mins by liquid scintillation spectrometry analysis relative to control2021Journal of natural products, 01-22, Volume: 84, Issue:1
Phytocannabinoid Pharmacology: Medicinal Properties of
AID1845626Agonist activity at TRPA1 (unknown origin) activation assessed as efficacy relative to control2021Journal of natural products, 01-22, Volume: 84, Issue:1
Phytocannabinoid Pharmacology: Medicinal Properties of
AID1845627Agonist activity at TRPA1 (unknown origin) channel desensitization in presence of isothiocyanate2021Journal of natural products, 01-22, Volume: 84, Issue:1
Phytocannabinoid Pharmacology: Medicinal Properties of
AID1845604Antagonist activity at GPR55 (unknown origin) expressed in HEK293 cells assessed as LPI-stimulated ERK1/2 phosphorylation by measuring efficacy relative to control2021Journal of natural products, 01-22, Volume: 84, Issue:1
Phytocannabinoid Pharmacology: Medicinal Properties of
AID1845606Displacement of [35S]GTPgammaS from 5HT1A in human CHO cells by measuring efficacy incubated for 60 mins by radioligand binding assay relative to control2021Journal of natural products, 01-22, Volume: 84, Issue:1
Phytocannabinoid Pharmacology: Medicinal Properties of
AID1845621Agonist activity at ionomycin-stimulated TRPV4 (unknown origin) activation2021Journal of natural products, 01-22, Volume: 84, Issue:1
Phytocannabinoid Pharmacology: Medicinal Properties of
AID1524905Cytotoxicity against human PC3 cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay2019Bioorganic & medicinal chemistry letters, 05-01, Volume: 29, Issue:9
Analyzing the role of cannabinoids as modulators of Wnt/β-catenin signaling pathway for their use in the management of neuropathic pain.
AID1524911Cytotoxicity against human MCF7 cells assessed as reduction in cell viability incubated for 24 to 72 hrs by MTT assay2019Bioorganic & medicinal chemistry letters, 05-01, Volume: 29, Issue:9
Analyzing the role of cannabinoids as modulators of Wnt/β-catenin signaling pathway for their use in the management of neuropathic pain.
AID1625155Inhibition of MAGL in African green monkey COS cell homogenates at 50 uM using [3H]-arachidonoylglycerol as substrate measured after 20 mins by scintillation counting method relative to control2019Journal of natural products, 03-22, Volume: 82, Issue:3
Plant-Based Modulators of Endocannabinoid Signaling.
AID1625163Inhibition of [14C]-AEA uptake in rat RBL2H3 cells at 25 uM by scintillation counting method relative to control2019Journal of natural products, 03-22, Volume: 82, Issue:3
Plant-Based Modulators of Endocannabinoid Signaling.
AID1524903Cytotoxicity against human A549 cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay2019Bioorganic & medicinal chemistry letters, 05-01, Volume: 29, Issue:9
Analyzing the role of cannabinoids as modulators of Wnt/β-catenin signaling pathway for their use in the management of neuropathic pain.
AID1845620Agonist activity at ionomycin-stimulated TRPV3 (unknown origin) channel desensitization in presence of carvacrol2021Journal of natural products, 01-22, Volume: 84, Issue:1
Phytocannabinoid Pharmacology: Medicinal Properties of
AID1845616Agonist activity at ionomycin-stimulated TRPV2 (unknown origin) activation assessed as efficacy relative to control2021Journal of natural products, 01-22, Volume: 84, Issue:1
Phytocannabinoid Pharmacology: Medicinal Properties of
AID1845597Inhibition of TRPV5 channel (unknown origin) by Patch-clamp assay2021Journal of natural products, 01-22, Volume: 84, Issue:1
Phytocannabinoid Pharmacology: Medicinal Properties of
AID1524910Cytotoxicity against human A549 cells assessed as reduction in cell viability incubated for 24 to 72 hrs by MTT assay2019Bioorganic & medicinal chemistry letters, 05-01, Volume: 29, Issue:9
Analyzing the role of cannabinoids as modulators of Wnt/β-catenin signaling pathway for their use in the management of neuropathic pain.
AID1524914Cytotoxicity against human SH-SY5Y cells assessed as reduction in cell viability incubated for 24 to 72 hrs by MTT assay2019Bioorganic & medicinal chemistry letters, 05-01, Volume: 29, Issue:9
Analyzing the role of cannabinoids as modulators of Wnt/β-catenin signaling pathway for their use in the management of neuropathic pain.
AID1845613Agonist activity at ionomycin-stimulated TRPV1 (unknown origin) activation assessed as efficacy relative to control2021Journal of natural products, 01-22, Volume: 84, Issue:1
Phytocannabinoid Pharmacology: Medicinal Properties of
AID1546674Binding affinity to human CB1 receptor2020Journal of natural products, 01-24, Volume: 83, Issue:1
Isolation of a High-Affinity Cannabinoid for the Human CB1 Receptor from a Medicinal
AID1845617Agonist activity at ionomycin-stimulated TRPV2 (unknown origin) channel desensitization in presence of lysophosphatidylcholine2021Journal of natural products, 01-22, Volume: 84, Issue:1
Phytocannabinoid Pharmacology: Medicinal Properties of
AID1782665Inhibition of human LDHB assessed as reduction in lactate production using pyruvate as substrate at 10 uM in presence of NADH by spectrophotometric analysis relative to control2021Journal of natural products, 05-28, Volume: 84, Issue:5
Cannabichromene and Δ
AID1845600Agonist activity at human CB2 receptor transfected in CHO cells assessed as inhibition of cyclic AMP production2021Journal of natural products, 01-22, Volume: 84, Issue:1
Phytocannabinoid Pharmacology: Medicinal Properties of
AID1625161Inhibition of recombinant human NAAA expressed in HEK293 cells at 50 uM using [14C]-N-palmitoylethanolamine as substrate measured after 30 mins by beta-counting method relative to control2019Journal of natural products, 03-22, Volume: 82, Issue:3
Plant-Based Modulators of Endocannabinoid Signaling.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (7)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's3 (42.86)24.3611
2020's4 (57.14)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (14.29%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other6 (85.71%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]